Joint recommendations for retinal screening in long‐term users of hydroxychloroquine and chloroquine in the United Kingdom, 2018
Hydroxychloroquine has become established in the management of various forms of cutaneous lupus, photosensitive dermatoses, porphyria cutanea tarda, cutaneous sarcoid, lichen planus and other inflammatory dermatological diseases.1 Dermatologists who prescribe hydroxychloroquine should be aware of ne...
Main Authors: | Yusuf, IH, Lotery, AJ, Ardern-Jones, MR |
---|---|
Format: | Journal article |
Published: |
Wiley
2018
|
Similar Items
-
The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary
by: Yusuf, IH, et al.
Published: (2018) -
New recommendations for retinal monitoring in hydroxychloroquine users: Baseline testing is no longer supported
by: Yusuf, IH, et al.
Published: (2021) -
The Royal College of Ophthalmologists recommendations on monitoring for hydroxychloroquine and chloroquine users in the United Kingdom (2020 revision): executive summary
by: Yusuf, IH, et al.
Published: (2021) -
Requirement for retinal screening in patients taking hydroxychloroquine and chloroquine
by: Lotery, A, et al.
Published: (2018) -
Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom
by: Yusuf, I, et al.
Published: (2021)